Support PenkeTG Therapeutics Inc - Trending symbols
Latest News of TG Therapeutics Inc
| Date | Title | Read |
|---|---|---|
| 2025-06-17 13:38 | Exploring High Growth Tech Opportunities in US Markets | Read |
| 2025-06-13 13:21 | Analysts See 16% Upside For XSMO | Read |
| 2025-06-06 19:36 | TG Therapeutics (NasdaqCM:TGTX) Stock Rises 13% In Last Month | Read |
Trends
| 2024-03-31 | 2024-06-30 | 2024-09-30 | 2024-12-31 | 2025-03-31 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Net Debt | 36,192 | -6,564 | 29,628 | 28,358 | 57,986 | 15,839 | 73,825 | -196,988 | -123,163 | |
| Retained Earnings | -1,566,265 | -47,610 | -1,613,875 | 113,930 | -1,499,945 | -14,416 | -1,514,361 | 3,039,429 | 1,525,068 | |
| Cash And Cash Equivalents | 61,469 | 35,540 | 97,009 | 132,150 | 229,159 | -136,226 | 92,933 | -310,441 | -217,508 | |
| Long-term Assets Other | 3,087 | -81 | 3,006 | -123 | 2,883 | -1,468 | 1,415 | -218,923 | -217,508 | |
| Long-term Assets | 12,575 | -295 | 12,280 | -327 | 11,953 | -309 | 11,644 | -229,152 | -217,508 | |
| Other Stockholders Equity | -146 | -3 | -149 | -2 | -151 | 0 | -151 | 1,674,863 | 1,674,712 | |
| Total Stockholder Equity | -1,527,033 | -39,232 | -1,566,265 | -47,610 | -1,613,875 | 113,930 | -1,499,945 | 1,660,447 | 160,502 | |
| Liabilities and Stockholders Equity | -1,392,048 | -4,292 | -1,396,340 | -37,134 | -1,433,474 | 99,827 | -1,333,647 | 1,663,234 | 329,587 | |
| Income before Tax | -35,818 | -17,176 | -52,994 | 13,762 | -39,232 | -8,378 | -47,610 | 161,540 | 113,930 | |
| Net Income | -36,673 | -17,251 | -53,924 | 15,296 | -38,628 | -8,982 | -47,610 | 161,540 | 113,930 | |
| EBITDA | -34,041 | -16,091 | -50,132 | 13,744 | -36,388 | -7,595 | -43,983 | 158,767 | 114,784 | |
| Operating Income | -34,963 | -17,099 | -52,062 | 15,070 | -36,992 | -7,682 | -44,674 | 159,458 | 114,784 | |
| Net Income from Continuing Operations | -33,315 | -15,886 | -49,201 | 9,969 | -39,232 | -8,378 | -47,610 | 161,540 | 113,930 | |
| EBIT | -34,963 | -17,099 | -52,062 | 15,070 | -36,992 | -7,682 | -44,674 | 159,332 | 114,658 | |
| Total Other Income Expense Net | -1,569 | 714 | -855 | -77 | -932 | -1,308 | -2,240 | 2,931 | 691 | |
| Total Assets | 303,028 | -51,362 | 251,666 | -33,775 | 217,891 | -24,319 | 193,572 | -1,589,912 | -1,396,340 | |
| Income Tax Expense | 2,141 | -572 | 1,569 | -714 | 855 | 75 | 930 | -1,534 | -604 | |
| Total Operating Expenses | 78,888 | 7,978 | 86,866 | 8,192 | 95,058 | -26,407 | 68,651 | -108,186 | -39,535 | |
| Selling General Administrative | 34,017 | 882 | 34,899 | 21,560 | 56,459 | -33,955 | 22,504 | -38,446 | -15,942 | |
| Interest Expense | 1,623 | -585 | 1,038 | 41 | 1,079 | 1,585 | 2,664 | -5,681 | -3,017 | |
| Research Development | 44,871 | 7,096 | 51,967 | -13,368 | 38,599 | 7,548 | 46,147 | -48,475 | -2,328 |
Comments
How you think about this?